Epstein Secrets

dents - past and present - must make the most of this one." Vatican Dismisses US Concerns, Extends Agreement With China On Bishops. The AP (10/22, Winfield) reports that on Thursday, the Vatican and China "extended a controversial accord on bishop nominations...over strong opposition from the White Hous

WHO study, which was not 'blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

With China On Bishops. The AP <https://apnews.corn/article/beijing-china-pope-francis-europe-vatican-city- 5c5f822b98317fIbb5002887e3834731> (10/22, Winfield) reports that on Thursday, the Vatican and China "extended a controversial accord on bishop nominations...over strong opposition from the White Hous

used." Bloomberg <https://www.bloomberg.cotn/news/articles/2020-10-22/gilead-virus-therapy-remdesivir-gains- approval-from-fda?srnd-premium> (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

ongo's interior ministry said." Attanasio's bodyguard, Vittorio Iacovacci was also killed, as well as driver Mustapha Milambo. The AP (2/22, Kamale, Winfield), the New York Times (2/22, Specia, Pianigiani, 20.6M), the Washington Post (2/22, Bearak, 10.52M), and Politico Europe (2/22, 15K) have more cover

believes in science, not conspiracy theories." FDA Outlines Fast Path For New Vaccines, Booster Shots To Cover New Virus Variants. Bloomberg (2/22, Langreth, Cortez, 3.57M) reports, "Drugmakers won't have to perform massive trials for new vaccines or booster shots developed to combat worrisome new varian

idents - past and present - must make the most of this one." Vatican Dismisses US Concerns, Extends Agreement With China On Bishops. The AP (10/22, Winfield) reports that on Thursday, the Vatican and China "extended a controversial accord on bishop nominations...over strong opposition from the White Hous

WHO study, which was not `blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so